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Objective: In 1996 Sgarbossa reviewed 17 ventricular-paced electrocardiograms (ECGs) in acute 
myocardial infarction (AMI) for signs of ischemia. Several characteristics of the paced ECG were 
predictive of AMI. We sought to evaluate the criteria in ventricular-paced ECGs in an emergency 
department (ED) cohort.
Methods:	Ventricular-paced ECGs in patients with elevated cardiac markers within 12 hours of the 
ED ECG and a diagnosis of AMI were identified retrospectively (n=57) and compared with a control 
group of patients with ventricular-paced ECGs and negative cardiac markers (n=99). A blinded board 
certified cardiologist reviewed all ECGs for Sgarbossa criteria. This study was approved by the 
institutional review board.
Results: Application of Sgarbossa’s criteria to the paced ECGs revealed the following: 
1) The sensitivity of “ST-segment elevation of 1 mm concordant with the QRS complex” was unable 
to be calculated as no ECG fit this criterion; 
2) For “ST-segment depression of 1 mm in lead V1, V2, or V3,” the sensitivity was 19% (95% CI 11-
31%), specificity 81% (95% CI 72-87%), with a likelihood ratio of 1.06 (0.63-1.64); 
3) For “ST-segment elevation >5mm discordant with the QRS complex,” the sensitivity was 10% 
(95% CI 5-21%), specificity 99% (95% CI 93-99%), with a likelihood ratio of 5.2 (1.3 - 21).
Conclusion:	In our review of ventricular-paced ECGs, the most clinically useful Sgarbossa 
criterion in identifying AMI was ST-segment elevation >5mm discordant with the QRS complex. 
This characteristic may prove helpful in identifying patients who may ultimately benefit from early 
aggressive AMI treatment strategies. [West J Emerg Med. 2010; 11(4):354-357.]
INTRODUCTION
Establishing the diagnosis of acute myocardial infarction 
(AMI) in the setting of a ventricular paced rhythm (VPR) is a 
difficult task and often results in delay of definitive treatment. 
In a 2001 retrospective cohort study, patients with a VPR were 
significantly less likely to receive emergent reperfusion and 
aspirin.1 These paced patients were noted to have an increased 
long-term mortality rate when compared with non-paced 
controls, even after accounting for disease severity.
In the emergency department (ED), the diagnosis of AMI 
still relies primarily on history and the 12-lead 
electrocardiogram (ECG). Publications examining the utility 
of the ventricular paced ECG in the evaluation of acute chest 
pain have been limited to case reports, case series and review 
articles.2-5 Occasionally, the intermittent presence of a native 
rhythm or progressive ECG changes may aid in the diagnosis 
of AMI.6,7 The diagnostic accuracy of the ECG in the absence 
of these findings, however, has not been thoroughly 
evaluated. 
In 1996 Sgarbossa published a retrospective review of 17 
ventricular paced ECGs with AMI confirmed by cardiac 
biomarkers, compared with 17 ventricular-paced controls.8 In Volume XI, no. 4  :  September 2010  355  Western Journal of Emergency Medicine
this study, several characteristics of the paced ECG were 
examined for findings that might be predictive of AMI. 
Three findings appear to have low sensitivities, but 
potentially clinically useful specificities: 1) ST elevation 
>1mm in leads with a predominantly positive QRS (sensitivity 
18%, specificity 94%); 2) ST segment elevation of >5mm in 
leads with predominantly negative QRS (sensitivity 55%, 
specificity 88%); 3) ST depression >1mm in v1, v2, v3 
(sensitivity 29%, specificity 82%). 
As this initial study had relatively small numbers (34 total 
patients), we sought to revisit the sensitivity and specificity 
calculations by reviewing a larger cohort of patients. 
METHODS
This study is a chart review to identify a gold standard 
with de novo cardiology review of ECGs. The chart review 
identified existing patient records with paced ECGs who had 
an AMI. For this study, AMI is defined as a rise/and or fall of 
cardiac biomarker with at least one value above the most 
stringent manufacturer recommended cutoff or the suggestion 
of the hospital laboratory and a discharge International 
Disease Classification 9 (ICD-9) code of AMI (410.XX). This 
study was approved by the institutional review board.
The study reviewed records from two sites. Site A is a 
large tertiary care center with an ED volume of approximately 
70,000 visits per year. Cardiologists’ reads of ECGs are stored 
electronically and are searchable. ECGs of interest were 
identified by searching the text of the readings for “electronic 
pacemaker.” These patients were then searched for a Troponin 
I greater than 0.8 Ng/ml (normal reference 0.000-0.080 Ng/ml 
before 2/1/08 and 0.000-0.120 after 2/1/08) within 12 hours of 
the ECG being performed. The cutoff of 0.8 Ng/ml was 
chosen as it is the most stringent manufacturer recommended 
criteria according to the American College of Emergency 
Physician clinical policies.9 First, minimum and maximum 
Troponin I levels and times of the test were recorded. When 
available, cardiac catheterization information (at the minimum 
date and time of catheterization) was recorded as well. 
Controls for Site A were identified in a similar way to those 
with AMI, except that each control had at least one Troponin I 
performed, and all Troponin I’s performed during that hospital 
stay were less than 0.080 Ng/ml.
Site B is a large community hospital with an ED volume 
of 100,000 visits per year. Unlike Site A, Site B does not store 
their ECG reads electronically. The search strategy for Site B 
consisted of identifying ED patients with a history of a 
permanent pacemaker by ICD-9 code (V45.01) recorded at 
that hospital. These were then searched for a Troponin I 
greater than 2 Ng/ml (reference range 0.0-0.3 Ng/ml before 
5/1/04 and 0.0-0.1 Ng/ml after 5/1/04) within 12 hours of 
admission from the ED. A Troponin I of >2Ng/ml was defined 
as abnormal by the hospital laboratory from 8/16/98 onward. 
ED ECGs are routinely scanned into the medical information 
system with the ED chart with a unique, searchable code 
identifying them as ECGs. One abstracter searched all scanned 
ECGs to identify those whose machine interpretation was a 
paced rhythm. The abstracter then recorded the first value, 
minimum and maximum Troponin I values and times of the 
test.
Controls from Site B were identified in a similar way to 
those with AMI except that each control had at least one 
Troponin I performed and all Troponin I’s performed during 
that hospital stay were less than 0.1 Ng/ml.
ECGs were de-identified and given a random number in a 
sequence. A blinded cardiologist reviewed these ECGs for 
signs of ischemia according to Sgarbossa criteria. When 
reproduction of the ECG changed the mV scale, the 
cardiologist adjusted appropriately (e.g., when the 10mm 
standard was measured at 8mm secondary to xeroxing 
adjustment, the 5mm discordance criteria was adjusted to 
4mm).
Results were calculated using R (Vienna, Austria) version 
2.7.2 with package DiagnosisMed version 0.0.2.10,11 Microsoft 
Excel (Redmond, Washington) Version 11.5 was used for 
summary statistics.
RESULTS
For the ventricular-paced acute myocardial infarction 
(VPAMI) group, 72 paced ECGs with positive Troponin I 
were identified from Site A from December 1, 2002 to April 1, 
2008. 39 were not coded as acute MI at hospital discharge. 
This left 33 ECGs from Site A. At Site B, 35 paced ECGs with 
positive Troponin I were identified from Site A from 
December 1, 2002 to April 1, 2008. Ten of these were not 
coded as AMI at hospital discharge. This left 25 ECGs from 
Site B, for a total of 58 ECGs in the VPAMI group.
For the control group, 101 ECGs with negative Troponin I 
were randomly selected. 100 was chosen as it was estimated 
there might be approximately 100 VPAMI ECGs.
When the cardiologist reviewed the ECGs, three were 
excluded (one control ECG and two ECGs from the VPAMI 
group) due to the presence of atrial pacers in two ECGs and 
missing information from lead V4 in an additional ECG. This 
left 57 ECGs from the VPAMI group and 99 control ECGs. 
The cardiologist also noted that seven ECGs (four potentially 
ischemic and three control) were recorded at one-half standard 
voltage; these were kept in the cohort, but 1/2 voltage 
Sgarbossa criteria were used. Only one ECG met more than 
one criteria (Score 3 and 2). This ECG was a control ECG and 
it was entered twice for data analysis.
The average age and sex distribution in the VPAMI group 
was 76.0 years with 63% male patients, while the control 
group averaged 73.8 years with 63% male patients.
Application of the Sgarbossa criteria to the ECGs found 
the following: 
1) The sensitivity of ST-segment elevation 1 mm and 
concordant with QRS complex was unable to be calculated as 
none of the VPAMI ECGs fit this criteria. 
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2) For ST-segment depression 1 mm in lead V1, V2 or V3, the 
sensitivity was 19% (95% CI 11-31%), specificity 81% (95% 
CI 72-87%) and likelihood ratio 1.06 (0.63-1.64). 
3) For ST-segment elevation >5mm and discordant with QRS 
complex, the sensitivity was 10% (95% CI 5-21%), specificity 
99% (95% CI 93-99%) and a likelihood ratio of 5.2 (1.3 - 21).
DISCUSSION
We evaluated 57 ventricular-paced ECGs admitted and 
discharged with an elevated serum troponin and an ultimate 
diagnosis of AMI. This number represents to our knowledge 
the largest study population to date examining the diagnosis of 
AMI in the setting of a ventricular-paced ECG. We sought to 
evaluate the sensitivity and specificity analysis of Sgarbossa 
using 99 paced ECGs with normal serum troponins as the 
control group. 
Using the criterion of ST segment elevation of 1mm with 
concordant QRS complex resulted in a sensitivity and 
specificity that could not be calculated as none of the VPAMI 
or control ECGs fit this criterion. It was noted to be the most 
specific finding in Sgarbossa’s study (94% specificity) and 
was thus assigned the highest point value. In our study, the 
criteria of ST segment elevation >5mm and discordant with 
the QRS complex had the highest specificity (99%), but a low 
sensitivity (10%) when compared with Sgarbossa’s study 
(specificity 88% with a sensitivity of 53%). The criteria of 
ST-segment depression in V1, V2 or V3 had similar test 
characteristics to Sgarbossa’s study (sensitivity of 19%, 
specificity of 81% compared with a sensitivity of 29% and 
specificity of 82% in Sgarbossa’s study). This criterion’s test 
characteristics make it of limited value given its unacceptably 
high false positive and false negative rate. 
The results of our study indicate that the ventricular-paced 
ECG is of little diagnostic value in ruling out the diagnosis of 
AMI using Sgarbossa criteria, but may be helpful in ruling in 
the diagnosis. Our key finding of applying Sgarbossa’s criteria 
to paced ECGs, specifically the presence of ST segment 
elevation >5mm in leads with a discordant QRS, shows high 
specificity (99%) for the diagnosis of acute MI. The low 
sensitivity of ECG criteria for AMI in this study is consistent 
with a recent study by Kontos el al. They found that of 1641 
patients with AMI, only 22% had diagnostic ST elevation 
on initial ECG..12 As prior studies have suggested, possible 
benefit of early reperfusion with percutaneous intervention 
in patients with paced ECGs13,14, the third Sgrabosssa criteria 
may be most useful in the ED setting to help rapidly identify 
patients to be considered for this intervention.
LIMITATIONS
Limitations of our study include the retrospective design 
and data collection. In addition, this study did not address 
in-hospital or long-term data regarding patient morbidity and 
mortality. ICD-9 codes and Troponin I values have inherent 
limitations in the diagnosis of AMI. Therefore, we chose to 
combine the two to ensure that the diagnosis was accurate. 
This likely excluded some ventricular- paced patients who had 
AMIs during the study time period. 
Due to problems with reproduction, our sample included 
four ECGs that did not reproduce at the correct size. 
These were scaled by the reviewing cardiologist adjusting 
the criterion measured 10mm standard boxes. These 
measurements were not tested for inter-observer variability. 
CONCLUSION
In our review of ventricular-paced ECGs, the most 
clinically useful Sgarbossa criterion in identifying AMI 
was ST-segment elevation >5mm discordant with the QRS 
complex. This criterion demonstrated a high specificity and 
low sensitivity suggesting that it may be helpful in identifying 
patients who could ultimately benefit from early, aggressive 
AMI treatment strategies. The clinical utility of the aggregate 
Sgarbossa criterion is questionable.
Address for Correspondence: Kevin Maloy, MD, Department of 
Emergency Medicine, Georgetown University Hospital, 3700 
Reservior Road NW, First Floor CCC Building, Washington, DC 
20057. Email maloykr@georgetown.edu
Conflicts of Interest: By the WestJEM article submission agreement, 
all authors are required to disclose all affiliations, funding sources, 
and financial or management relationships that could be perceived 
as potential sources of bias. The authors disclosed none.
REFERENCES	
1.  Rathore SS, Weinfurt KP, Gersh BJ. Treatment of patients with 
myocardial infarction who present with a paced rhythm. Ann Intern 
Med. 2001; 134:644-51.
2.  Madias JE. The nonspecificity of ST-segment elevation >or=5.0 mm 
in V1-V3 in the diagnosis of acute myocardial infarction in the 
presence of ventricular-paced rhythm. J Electrocardiol. 2004; 
37:135-9.
3.  Ufberg J, Harrigan RA, Wittenberg AJ. Acute myocardial infarction 
complicated by a ventricular-paced rhythm. J Emerg Med. 2004; 
27:81-3.
4.  Harper RJ, Brady WJ, Perron AD, et al. The paced 
electrocardiogram: issues for the emergency physician. Am J Emerg 
Med. 2001; 19:551-60.
5.  Kozlowski FH , Brady WJ. The electrocardiographic diagnosis of 
acute myocardial infarction in patients with ventricular-paced 
rhythms. Acad Emerg Med. 1998; 5:52-7.
6.  Brady WJ. Cases in electrocardiography. Am J Emerg Med. 1998; 
16:85-6. 
7.  Rosner MH, Brady WJ. The electrocardiographic diagnosis of acute 
myocardial infarction in patients with ventricular-paced rhythms. Am J 
Emerg Med. 1999; 17:182-5. Volume XI, no. 4  :  September 2010  357  Western Journal of Emergency Medicine
8.  Sgarbossa EB, Pinski SL, Gates KB, et al. Early electrocardiographic 
diagnosis of acute myocardial infarction in the presence of 
ventricular-paced rhythm. GUSTO-I investigators. Am J Cardiol. 
1996; 77:423-4.
9.  Jagoda AS, Decker WW, Edlow JA, et al. Clinical Policy: Critical 
Issues in the Evaluation and Management of Adult Patients with 
Non–ST-Segment Elevation Acute Coronary Syndromes. Ann Emerg 
Med. 2006; 48:270-301.
10.  R Development Core Team. R: A language and environment for 
statistical computing. Vienna, Austria; 2008. Version 2.7.2.
11.  Brasil P. DiagnosisMed: Diagnostic test accuracy evaluation for 
medical professionals. Vienna, Austria; 2008. Version 0.0.2.
12.  Kontos MC, Roberts BD, Tatum JL, et. al. Mortality based on the 
presenting electrocardiogram in patients with myocardial infarction in 
the troponin era. AJEM 2009; 27:146–152.
13.  Nunn CM, O’Neill WW, Rothbaum D. Long term outcome after primary 
angioplasty: report from the Primary Angioplasty in Myocardial 
Infarction (PAMI-I) trial. J Am Coll Cardiol. 1999; 33:640-6.
14.  Rathore SS, Gersh BJ, Weinfurt KP. The role of reperfusion therapy 
in paced patients with acute myocardial infarction. Am Heart J. 2001; 
142:516-9.
Maloy et al.  Sgarbossa Criteria